Drug Type CAR-T |
Synonyms EU 301, EU301 |
Target |
Mechanism HLA-DR blockers(HLA-DR antigens blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Leukemia | Preclinical | KR | 26 Jan 2025 | |
Diffuse Large B-Cell Lymphoma | Preclinical | KR | 26 Jan 2025 |